FUTURE-PROOF LABS TO ENSURE SUSTAINABLE PHARMA GROWTH

We are at the forefront of changes in the pharma environment and emerging AI/FutureTech trends to ensure pharma fast-solve their biggest business challenges through a results-orientated framework.

Reinventing Sustainable Success in the New World

The danger to pharma from multiple directions including the looming patent cliffs, advances in earlier diagnosis (from smart homes and wearables among other tech), DTx, nanobots and more, is that they preclude or exclude the need for traditional drugs. Drugs have their place in the future of medicine, but they are no longer the only player. Business models that treat them as such are doomed to fail in the coming years. Traditional therapies are not dead, but in the coming years they will be taking on a new smaller role, in a new arena driven by advances in technology, especially AI and big data.

A transformation is waiting to happen in pharma, and steps are already being taken as the focus is shifted to better clinical outcomes and value. But an important gap still exists between where we need to go and where we are now.

In order to not only survive, but thrive, pharma must keep up with innovation and the latest thinking, tools, and technology, and plan its strategy and AI/FutureTech centred around its customers (and not its own products) to evolve sustainable, long-term business models, and not just services and digitised ways of doing the same thing.

Some pharma have effectively embraced these changes and are being rewarded with double-digit growth, while others have some way to go to get there as evidenced by less than single-digit growth – or less. If you are in the latter group, consider one of our labs to help you turn that around.

Want to discuss how we can help?

Re-ignite Your Growth With Our LABS

We future-proof pharmaceutical companies in every part of the value chain to yield ongoing success using data. We deploy our proven frameworks to accelerate the organisation to achieve its mission with the most impactful AI and FutureTech strategies to create sustainable impact.

Reveal LAB

Give us your most difficult challenges to solve with the optimal AI and FutureTech!

To solve difficult challenges, you often need sophisticated technology. You know the challenges you face. The question is how to solve them. We provide a deep dive into where the opportunities are and then identify the optimal AI or FutureTech-enabled approach to give real-world measurable results that solve your specific challenge. Not just any AI, but an approach that solves your most pressing business challenge/s effectively. This can include being able to access new data sets, advanced artificial intelligence algorithms, APIs to connect old and new, and disruptive technologies to quickly solve challenges. We then assess the cost/feasibility and identify the use case/s and options to de-risk implementation and identify the optimal growth paths. This Lab enables you to solve your most complex challenge with AI/FutureTech.

Get in touch to find out more

Accelerate LAB

Ensuring the key foundational elements required for success in your AI/FutureTech projects are in place.

In the pharma environment, we face unique challenges. Knowing where you want to go is one thing, but getting there has some traps along the way. Very few AI projects are press ‘go’ and deliver. The trap many fall into is not ensuring that the key foundational elements are in place (e.g. finding the right data, getting through internal legal and compliance audits, buy vs build, tech planning SOW, choosing the optimal AI vendor etc.). We work with you to do the heavy lifting to ensure that all the core elements are dealt with effectively so that you can execute quickly. This Lab accelerates your ability to industrialise the opportunity effectively by taking care of all these foundation pieces enabling you to easily commercialise the most effective solutions rapidly and seamlessly.

Get in touch to find out more

Transformation LAB

Assess emerging risks, identify drivers and sources of sustainable competitive advantage, and how to leverage these for sustainable growth.

Technology is moving into every aspect of pharma, as well as their competitors which are now in adjacent spaces. Within this changing landscape, new risks and opportunities are emerging for pharma.

When looking at future-proofing, we need to align several areas including your USPs, the competitive landscape (and this includes big tech, AI start-ups and adjacent areas) and the relevant growth opportunities. We help you navigate this fast-changing environment and help you identify, analyse and operationalise approaches that not only address the emerging risks to your business, or your part of the value chain but also deliver strategic solutions that will yield the growth and future-proofing you need to thrive in the new normal and ever-changing world

Get in touch to find out more

REVEAL LAB: Creating Solutions

ACCELERATE LAB: Building the foundational elements

TRANSFORMATION ENGINE : Creating long-term sustainable growth

REVEAL LAB: Creating Solutions

ACCELERATE LAB: Building the foundational elements

TRANSFORMATION ENGINE : Creating long-term sustainable growth

Contact us today

"Andree is the only contact that I have kept over my working history in eBusiness because she adds consistent value when ever we meet. Andree is like a LASER; Focused with High Energy! Fuelled on espresso she never stops until she has done her best. Andree always strives for excellence in everything she does, she is truly International Business consultant as she speaks fluent Japanese and has enough air miles to bankrupt British Airways!"

"In many areas, her insight and experience have been very valuable references to my own efforts to promote innovative approaches in GSK Japan then, and now inside CMIC Holdings. I therefore endorse Dr. Bates."

The feedback I have received from students has been "amazing". I know you have a very busy schedule but do keep in touch with us. Your area of work is of great interest to our center.

"On behalf of CSL Behring Asia Pacific, I wish to sincerely thank you for delivering such a thought provoking session. As a learning organization, we could not have invited a better key note speaker."

"Pharma all want comp[any growth and profit. This is typically accomplished by two routes; one is mergers and acquisitions, the other is Dr Andree Bates."